*Comprehensive biochemistry panel | Comprehensive biochemical profile | Assesses liver function, kidney function, blood glucose, blood lipids, proteins, uric acid, electrolytes and overall systemic metabolism. | Request a hospital quote |
α-L-Fucosidase (AFU) | α-L-Fucosidase (AFU) assay | A clinician may interpret this alongside other tests in specific diagnostic or monitoring settings. It cannot diagnose or exclude cancer on its own and is not routine cancer screening for everyone without symptoms. | Request a hospital quote |
*Homocysteine | Homocysteine | Helps predict risk of cardiovascular events and stroke. | Request a hospital quote |
*Small dense low-density lipoprotein (sdLDL) | Small dense low-density lipoprotein (sdLDL) | Assists cardiovascular risk stratification. | Request a hospital quote |
*Glycated hemoglobin (HbA1c) | Glycated hemoglobin (HbA1c) | Reflects average blood glucose control over approximately the past 2–3 months; supports diabetes monitoring. | Request a hospital quote |
*Glycated albumin (GA) | Glycated albumin (GA) | Reflects glycemic control over approximately the past 2–4 weeks; useful for short-term glucose assessment. | Request a hospital quote |
*Free fatty acids | Free fatty acids | Evaluates lipid metabolism. | Request a hospital quote |
*Cystatin C | Cystatin C | Assesses renal function. | Request a hospital quote |
*Insulin | Fasting insulin | Evaluates pancreatic beta-cell insulin secretion. | Request a hospital quote |
*Vitamin B12 | Vitamin B12 | Screens for megaloblastic anemia; participates in homocysteine metabolism and aids cardiovascular risk factor assessment. | Request a hospital quote |
*Folate | Folate | Screens cardiovascular risk factors and evaluates nutritional status. | Request a hospital quote |
*Cortisol | Cortisol | Screens disorders such as exogenous/simple obesity-related patterns, adrenal hyperplasia and hypercortisolism. | Request a hospital quote |
*Thyroid function panel (seven tests) | FT3, FT4, TT3, TT4, anti-TG, anti-TPO, TSH | Evaluates thyroid function. | Request a hospital quote |
*Serum iron | Serum iron | Screens iron deficiency states and anemia. | Request a hospital quote |
*25-Hydroxyvitamin D [25(OH)D] | 25-Hydroxyvitamin D | Supports evaluation of bone and mineral metabolism. | Request a hospital quote |
*Parathyroid hormone (PTH) | Parathyroid hormone (PTH) | Primarily used to assess parathyroid function. | Request a hospital quote |
*Apolipoproteins | ApoA, ApoB | Assesses apolipoprotein levels and lipid transport. | Request a hospital quote |
*Creatine kinase-MB isoenzyme (CK-MB) | Creatine kinase-MB isoenzyme (CK-MB) | Screens myocarditis, myocardial infarction and other cardiac conditions. | Request a hospital quote |
*Serum protein electrophoresis | Serum protein electrophoresis | Helps screen for hematologic, rheumatologic, oncologic and immune-related disorders. | Request a hospital quote |
*Oxidized low-density lipoprotein (OxLDL) | Oxidized low-density lipoprotein cholesterol | Supports prevention, monitoring and early diagnosis of cardiovascular disease and lipid metabolism disorders. | Request a hospital quote |
*Apolipoprotein E (apoE) | Apolipoprotein E (apoE) | Associated with dyslipidemia, Alzheimer disease, atherosclerosis, coronary artery disease, Parkinson disease and stroke. | Request a hospital quote |
*Human epididymis protein 4 (HE4) Applicability: Female only | Human epididymis protein 4 (HE4) | A clinician may interpret this alongside other tests in specific diagnostic or monitoring settings. It cannot diagnose or exclude cancer on its own and is not routine cancer screening for everyone without symptoms. | Request a hospital quote |
*Expanded tumor markers (add-on) | CA125, NSE | A clinician may interpret this alongside other tests in specific diagnostic or monitoring settings. It cannot diagnose or exclude cancer on its own and is not routine cancer screening for everyone without symptoms. | Request a hospital quote |
*Thyrotropin receptor antibodies (TRAb) | Thyrotropin receptor antibody assay | Important ancillary test for Graves disease and autoimmune thyroid disorders. | Request a hospital quote |
*Hepatic fibrosis panel (four biomarkers) | Hepatic fibrosis four-marker panel | Supports diagnosis and staging of hepatic fibrosis. | Request a hospital quote |
*Bone turnover markers (three tests) | Osteocalcin, β–cross-linked C-telopeptide of type I collagen (β-CTX), total procollagen type I N-terminal propeptide (Total-P1NP) | Integrated evaluation of metabolic bone disease, bone turnover and systemic disorders affecting bone. | Request a hospital quote |
N-acetyl-β-D-glucosaminidase (NAG) | Urinary NAG | Elevated urinary NAG is an early sign of renal injury and a sensitive marker of tubular damage. | Request a hospital quote |
α1-Microglobulin (α1-MG) | Urinary α1-microglobulin (α1-MG) | Early marker of proximal tubular dysfunction. | Request a hospital quote |